Market

Novo Nordisk (NVO) is aimed at dominating the GLP-1 market News ad

by
Novo Nordisk (NVO) is aimed at dominating the GLP-1 market News ad

Novo Nordisk a/s. NYSE: NVO He announced that his GLP-1 drugs in chronic obesity, with Ozempic and Wegovy brands, are no longer in deficiency. This led to the fact that the United States Products and Medications Office took half -Glutid, an active ingredient in both, from a list of drug lack of drugs on February … Read more

Father’s market week in the review – 03/03 – 03/07 News ad

by
Father’s market week in the review – 03/03 – 03/07 News ad

The shares had another week, despite the February report on workplaces, which became easier than expected. The details of the report were generally optimistic, and government jobs received the biggest blow, as expected. This is just another magazine in the fire of uncertainty that sets fire to reserves, and there is no immediate catalyst to … Read more